Know about Carcinoa

SU-9055 is a 17-hydroxylase and IS-hydroxylase inhibitor. It produces inhibition of aldosterone but has not been used clinically to inhibit cortisol production. Aminoglutethimide is an anticonvulsant with the trade name of Elipten. It was withdrawn from the market because it tended to produce hirsutism and goiter. In patients with Cushing’s syndrome doses of I to 2 Gm/day have caused significant decreases in cortisol secretion. The drug acts by blocking synthesis at some point between cholesterol and pregnenolone. Benefit has also been observed in patients with Cushing’s syndrome due both to adrenocortical carcinoma and to adenoma.ICD10 Training Online. makes you spend more time with patients and increase the quality of the care.

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • Blogplay

Comments Off